Charles River will introduce four pain models (rat) for translational disease research this fall.
Theorem Clinical Research and Charles River Laboratories have formed an alliance that will provide nonclinical testing programs in the areas of bioanalysis, immunogenicity and immunology to support trials.
With fewer and fewer early-stage molecules moving through pipelines, CROs that used to count on early-phase business are having to get creative. For Charles River Laboratories, the key to success in an evolving market is delivering consistent quality.
Charles River Laboratories has partnered with eCRO Target Health and Theorem Clinical Research to support the transfer and validation of assays supporting the CROs’ preclinical programs.
Charles River Laboratories will add four new rat models to its drug discovery services which will provide more objective endpoints for companies developing pain medications, as well as those looking for a higher translation between discovery and first-in-human studies.
Virus filters are used in biomanufacturing to ensure the safety of biopharmaceutical drug products. As part of filter implementation, manufacturers are required to validate that the filtration process can indeed remove virus.
If you want to do basic research to develop all new molecules to conquer diseases that can't easily be conquered, chances are you'll have to hire Charles River Laboratories to do the testing. This company can do it faster and more cheaply than anyone else can. It is the acknowledged leader, and no one can dispute that.
Like many kids, Jim Foster helped out his father by putting in shifts at the family business while he was in junior high and high school. But when your father is Henry Foster, founder of Wilmington-based Charles River Laboratories, that classic childhood work experience involves cleaning the cages of lab animals - and even assisting with veterinary surgeries.
Mad Money host Jim Cramer recently interviewed Charles River CEO James Foster. In this interview, James Foster discusses Charles River's quarter, the impact from the sequester and the role Charles River plays in helping companies move their drugs into the pipeline.
Today’s tough challenges are forcing change in the pharmaceutical industry. Pharma talks to several service providers to discover how these changes are reshaping their business strategies and fortifying their alliances with pharma companies.